Thrombin-activatable fibrinolysis inhibitor aka procarboxypeptidase U

Source
Baltimore, Md, Lippincott, Williams & Wilkins, 2006,
Author(s)

Carboxypeptidase U (TAFIa): a metallocarboxypeptidase with a distinct role in haemostasis and a possible risk factor for thrombotic disease

Source
2005,

HMR 3339, a novel selective estrogen receptor modulator, reduces concentrations of procarboxypeptidase U, an inhibitor of fibrinolysis: a randomized, placebo-controlled study in postmenopausal women

Source
2005,
Author(s)